Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Presentations

The information set forth in the presentations posted on this page was factually accurate on the date it was issued. While these presentations remain on the Company's website, the Company assumes no duty to update the information to reflect subsequent developments. Consequently, listeners to the presentations should not rely upon the information as current or accurate after their issuance dates.

DateTitleWebcasts
06/13/18
Download DocumentationWilliam Blair 38th Annual Growth Stock Conference Presentation
 
05/16/18
Download DocumentationBank of America Merrill Lynch 2018 Health Care Conference Presentation
 
05/10/18
Download DocumentationCharles River Laboratories Q1 2018 Earnings Presentation
 
Get help downloading or viewing the above file types

Stock Quote

CRL (common)
Price
$116.21
Change (%)
+ 0.48 (0.41%)
Volume
576,475
Exchange
NYSE
Data as of 06/22/18 4:03 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)